Gastric inhibitory polypeptide

未知生产厂商

Gastric inhibitory polypeptide is under investigation in clinical trial NCT03081676 (The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without Sulphonylurea).

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

技术标识符

CAS 编号: 100040-31-1
UNII ID: 1O4H75S7H2

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

MODULATORS OF G-PROTEIN COUPLED RECEPTORS
- EP 3768294 A4
  申请人: CARMOT THERAPEUTICS INC优先权: 2018
  CN
  EP
  US
  WO
  6 件公开
- EP 4337682 A2
  申请人: CARMOT THERAPEUTICS INC优先权: 2021
  CN
  EP
  US
  WO
  6 件公开
Analogs of gastric inhibitory polypeptide and their use for treatment of diabetes
US 6921748 B1申请人: UUTECH LTD优先权: 1999
US
6 件公开
COMPOSITIONS AND METHODS FOR TREATING FATTY TISSUE BUILDUP
EP 4410833 A3申请人: MHS CARE INNOVATION LLC优先权: 2013
EP
US
5 件公开
Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
US 7572451 B2申请人: CYTOS BIOTECHNOLOGY AG优先权: 2005
US
4 件公开
COMBINATION THERAPY
EP 4735021 A1申请人: ZEALAND PHARMA AS优先权: 2023
CN
EP
WO
3 件公开
Compositions and methods for treating obesity and hyperphagia
US 10548951 B2申请人: MHS CARE INNOVATION LLC优先权: 2017
US
3 件公开
GIPR ANTIBODY AND FUSION PROTEIN BETWEEN SAME AND GLP-1, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
EP 4063385 A4申请人: GMAX BIOPHARM LLC优先权: 2019
EP
US
2 件公开
Novel analogues of glucose-dependent insulinotropic polypeptide
US 2005137135 A1申请人: HINKE SIMON A优先权: 2003
US
2 件公开
Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
US 2005245441 A1申请人: NYBERG JENNY优先权: 2005
US
2 件公开
Use of GIP for the treatment of disorders associated with dysfunctional synaptic transmission
US 9062125 B2申请人: FLATT PETER RAYMOND优先权: 2007
US
2 件公开

药物

Gastric inhibitory polypeptide

概览

专利

MODULATORS OF G-PROTEIN COUPLED RECEPTORS